Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Elasfy
- Development stage
- Unknown
- Lead developer
- Humedix
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Subdermal Injection, Intradermal Injection
01
Overview
Elasfy is an injectable dermal filler composed of cross-linked hyaluronic acid, designed for soft-tissue augmentation in aesthetic procedures. It is primarily indicated for the correction of moderate to severe facial wrinkles and folds, as well as for volume enhancement in areas such as the cheeks and lips. The mechanism of action involves the physical occupation of space within the dermal or subdermal layers, providing immediate structural support and volume. Additionally, the hydrophilic nature of the hyaluronic acid polymer helps to attract and retain water at the injection site, maintaining hydration and prolonging the aesthetic effect. While previously distributed by Vivid-Scientific, the product is manufactured by the South Korean company Humedix.
- Brand names
- Elasfy
- Other names
- Elasfy HA Filler
Beyond the preview
Go deeper on Elasfy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Elasfy.